FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 53 filers reported holding FORTRESS BIOTECH INC in Q2 2016. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $88,000 | -14.6% | 35,177 | -45.1% | 0.00% | – |
| Q3 2018 | $103,000 | -39.1% | 64,102 | +13.0% | 0.00% | – |
| Q2 2018 | $169,000 | -37.6% | 56,727 | -4.7% | 0.00% | – |
| Q1 2018 | $271,000 | +17.3% | 59,510 | +2.6% | 0.00% | – |
| Q4 2017 | $231,000 | -10.8% | 57,979 | -1.1% | 0.00% | – |
| Q3 2017 | $259,000 | -7.8% | 58,630 | -1.0% | 0.00% | – |
| Q2 2017 | $281,000 | +32.5% | 59,224 | +3.3% | 0.00% | – |
| Q1 2017 | $212,000 | +35.9% | 57,311 | -0.8% | 0.00% | – |
| Q4 2016 | $156,000 | -7.1% | 57,795 | +1.9% | 0.00% | – |
| Q3 2016 | $168,000 | +9.1% | 56,695 | -0.9% | 0.00% | – |
| Q2 2016 | $154,000 | -12.5% | 57,196 | +0.6% | 0.00% | – |
| Q1 2016 | $176,000 | +9.3% | 56,852 | -1.6% | 0.00% | – |
| Q4 2015 | $161,000 | +5.2% | 57,784 | -1.9% | 0.00% | – |
| Q3 2015 | $153,000 | -22.7% | 58,922 | 0.0% | 0.00% | – |
| Q2 2015 | $198,000 | – | 58,922 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Belmont Global Advisors, Inc. | 550,000 | $1,479,000 | 1.42% |
| Avoro Capital Advisors LLC | 1,326,636 | $3,569,000 | 0.79% |
| Geduld E E | 10,000 | $27,000 | 0.04% |
| ELLIOTT MANAGEMENT CORP | 1,074,707 | $2,891,000 | 0.02% |
| HighPoint Advisor Group LLC | 14,230 | $42,000 | 0.02% |
| Acrospire Investment Management LLC | 7,179 | $19,000 | 0.01% |
| B. Riley Wealth Advisors, Inc. | 24,100 | $65,000 | 0.01% |
| ClariVest Asset Management LLC | 117,719 | $316,000 | 0.01% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 15,985 | $43,000 | 0.01% |
| DENVER INVESTMENT ADVISORS LLC | 26,908 | $72,000 | 0.00% |